Rezolute, Inc. - חוב לטווח קצר של החברה RZLT

Rezolute, Inc. (RZLT) operations are characterized by minimal environmental impact and strict adherence to disposal regulations. The business relies on creating unique therapeutic solutions for rare pathologies, ensuring global reach and high profitability. The price action of the securities on GURU.Markets recorded a value of 0.00. However, risk remains significant due to a lack of sales and dependence on the outcome of drug trials for hyperinsulinemia.

Rezolute, Inc. (RZLT) develops unique therapies for rare metabolic pathologies, maintaining a monopoly status in the treatment of hyperinsulinism. This indicator aggregates all obligations with a maturity of up to one year, measuring the current accounts payable burden. Analyzing this metric allows for an assessment of the issuer's ability to service debt without compromising liquidity. Rising borrowings signal refinancing risks amid market turbulence. The trajectory of short-term debt clearly captures the dynamics of the business's financial stability.